Dáil Éireann Debate, Wednesday - 24 March 2021
1777. Deputy Alan Farrell asked the Minister for Health the status of efforts to approve dupilumab, commonly known as Dupixent, used to treat eczema and asthma among other conditions; and if he will make a statement on the matter. [15426/21]
View answerThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
